Events2Join

Medscape InDiscussion


S2 Episode 1: Psoriatic Arthritis and Disease Activity Measures

This transcript has been edited for clarity. Stanley Cohen, MD: I am Dr Stanley Cohen and welcome to Medscape's InDiscussion series on ...

Episode 1: The Evolution of Managing Severe COVID-19 Since 2020

Welcome to Medscape's InDiscussion series on COVID-19. Today we'll discuss how we first addressed severe COVID in 2020, what we have learned ...

Medscape InDiscussion - Felicia Chow Research Group

Medscape InDiscussion. Episode 6: Brain on Rapid Fire: Viruses, Mycoses, Amoeba, and More. September 12, 2023. With Karen C. Bloch, MD, MPH. Medscape ...

Medscape InDiscussion: Cardiorenal Metabolic Syndrome - YouTube

Share your videos with friends, family, and the world.

Episode 3: What's Your Approach? Treating Myelofibrosis - Medscape

Tania Jain, MBBS: Hello everyone, and welcome to the myelofibrosis (MF) podcast for Medscape InDiscussion. I'm your host, Tania Jain, and we ...

Episode 1: When Is CAR T-Cell Therapy the Answer? - Medscape

I'm Dr Amelia Langston. Welcome to Medscape's InDiscussion series on chimeric antigen receptor (CAR) T-cell therapy. Today we're going to start ...

S2 Episode 4: How Patient Advocacy Is Transforming IPF Research ...

Welcome to season 2 of the Medscape InDiscussion podcast series on idiopathic pulmonary fibrosis (IPF). Today, we're going to be discussing ...

Medscape InDiscussion: Type 2 Diabetes | Podcast on Spotify

Listen to Medscape InDiscussion: Type 2 Diabetes on Spotify. Listen to Medscape InDiscussion: Type 2 Diabetes, a podcast series where thought leaders and ...

S2 Episode 1: Use Social Media as a Force of Light in Cardiology

Kittleson, MD, PhD: Welcome to Medscape InDiscussion: Heart Failure. I'm your host, Dr Michelle Kittleson. This is the first episode of our ...

Medscape InDiscussion: Myasthenia Gravis | Podcasts on Audible

Listen to Medscape InDiscussion: Myasthenia Gravis, a podcast series where thought leaders and clinical experts share their diverse insights and ...

Medscape InDiscussion: Psoriasis | Podcast on Spotify

Listen to Medscape InDiscussion: Psoriasis on Spotify. Listen to Medscape InDiscussion: Psoriasis, a podcast series where thought leaders and clinical ...

Medscape InDiscussion: Psoriatic Arthritis - Apple Podcasts

Listen to Medscape's Medscape InDiscussion: Psoriatic Arthritis podcast on Apple Podcasts.

S2 Episode 4: Cancer Survivorship and Accelerated Aging

Ann H. Partridge, MD, MPH: Hello. I'm Dr Ann Partridge. Welcome to season 2 of the Medscape InDiscussion podcast series on cancer survivorship.

Medscape InDiscussion: Psoriasis - Apple Podcasts

Listen to Medscape InDiscussion: Psoriasis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for ...

S2 Episode 6: Pediatric Asthma: When Is It an Emergency?

Michael Wechsler, MD: Hello. I'm Dr Mike Wechsler. Welcome to Medscape's InDiscussion series on moderate to severe asthma. Today we'll be ...

Medscape InDiscussion: Crohn's Disease - Science Podcast

6 episodes. Join Dr Peter Higgins for Medscape InDiscussion: Crohn's Disease, a podcast series where thought leaders and clinical experts share their ...

Medscape InDiscussion: Psoriatic Arthritis (Podcast) - Listen Notes

Join Dr Stanley Cohen for Medscape InDiscussion: Psoriatic Arthritis, a podcast series where thought leaders and clinical experts share their diverse ...

Medscape InDiscussion: Crohn's Disease | Podcasts on Audible

Join Dr Peter Higgins for Medscape InDiscussion: Crohn's Disease, a podcast series where thought leaders and clinical experts share their diverse ...

Episode 1: Risk Stratification in Myelofibrosis: Which Model to Use?

Tania Jain, MBBS: Hi, everyone. I'm Tania Jain, and I welcome you all to season 1 of the Medscape InDiscussion podcast series on myelofibrosis.

The Role of Adjuvant and Neoadjuvant Therapy in Melanoma

Sapna Patel, MD: Hello, I'm Dr Sapna Patel and welcome to Medscape's InDiscussion series on melanoma. This is episode number one. Today we ...